PBA following Stroke

LIVING WITH PBA BEFORE TREATMENT

Discussing PBA

Watch video

Discussing PBA (Stroke LTC) (0:23)

AFTER TREATMENT WITH NUEDEXTA

Discussing PBA After Treatment

Watch video

Discussing PBA After Treatment (Stroke LTC) (2:12)

PBA following TBI

LIVING WITH PBA BEFORE TREATMENT

Patient with PBA

Watch video

Patient with PBA (TBI) (0:59)

LIVING WITH PBA BEFORE TREATMENT

Spouse Discussing PBA

Watch video

Spouse Discussing PBA (TBI) (0:45)

AFTER TREATMENT WITH NUEDEXTA

Patient with PBA

Watch video

Patient with PBA (TBI) (2:54)

AFTER TREATMENT WITH NUEDEXTA

Spouse Discussing PBA

Watch video

Spouse Discussing PBA (TBI) (2:16)

PBA following MS

DISCUSSING PBA

Barriers to identifying PBA

Watch video

Barriers to identifying PBA (MS) (0:30)

NUEDEXTA is approved for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurologic conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the underlying emotional state. PBA is a specific condition, distinct from other types of emotional lability that may occur in patients with neurological disease or injury.31

Information presented here represent specific cases; individual results may vary.

These videos are based on the information reported by the patients' healthcare providers and are not intended to be complete representations of the patients' medical histories. PBA can only be diagnosed upon evaluation by a healthcare provider.